World
Pfizer, BioNTech Covid Vaccine Cleared for Human Tests
- BioNTech’s shares soar after regulator gives go-ahead
- Testing on 200 healthy people in Germany to start shortly
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Pfizer Inc. and BioNTech SE secured approval for Germany’s first human clinical trials of a possible coronavirus vaccine, entering a global race to develop a defense against the pandemic.